Novartis
NVS
#68
Rank
NZ$340.35 B
Marketcap
$170.24
Share price
-0.23%
Change (1 day)
8.49%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$55.66 Billion

According to Novartis's latest financial reports the company's total debt is NZ$55.66 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novartis - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$41.66 B-5.22%
2022-12-31NZ$43.95 B-3.22%
2021-12-31NZ$45.42 B-13.42%
2020-12-31NZ$52.46 B21.22%
2019-12-31NZ$43.27 B-9.53%
2018-12-31NZ$47.84 B19.53%
2017-12-31NZ$40.02 B17.05%
2016-12-31NZ$34.19 B6.86%
2015-12-31NZ$31.99 B23.15%
2014-12-31NZ$25.98 B19.19%
2013-12-31NZ$21.80 B-9.08%
2012-12-31NZ$23.97 B-7.49%
2011-12-31NZ$25.91 B-12.84%
2010-12-31NZ$29.73 B55.31%
2009-12-31NZ$19.14 B57.96%
2008-12-31NZ$12.12 B66.03%
2007-12-31NZ$7.30 B-28.71%
2006-12-31NZ$10.24 B-14.72%
2005-12-31NZ$12.01 B30.68%
2004-12-31NZ$9.19 B9.2%
2003-12-31NZ$8.41 B-15.93%
2002-12-31NZ$10.01 B-8.96%
2001-12-31NZ$10.99 B29.73%
2000-12-31NZ$8.47 B-28.91%
1999-12-31NZ$11.92 B-3.01%
1998-12-31NZ$12.29 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$65.99 B 18.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$115.30 B 107.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$61.87 B 11.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$44.06 B-20.83%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$37.19 B-33.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$33.36 B-40.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$88.96 B 59.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.92 B-53.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$54.62 B-1.86%๐Ÿ‡ฌ๐Ÿ‡ง UK